MF
NEO icon

Manchester Financial’s NeoGenomics NEO Stock Holding History

Manchester Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-38
Closed -$2K – 437
2021
Q1 		$2K Hold
38
– – ﹤0.01% 633
2020
Q4 		$2K Hold
38
– – ﹤0.01% 540
2020
Q3 		$1K Hold
38
– – ﹤0.01% 527
2020
Q2 		$1K Hold
38
– – ﹤0.01% 494
2020
Q1 		$1K Sell
38
-550
-94% -$16.5K ﹤0.01% 473
2019
Q4 		$17K Buy
+588
New +$14K 0.01% 290
2019
Q3 		– Sell
-38
Closed -$1K – 297
2019
Q2 		$1K Buy
+38
New +$834 ﹤0.01% 472

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Manchester Financial's NEO Position: Q2 2021 in Review

Manchester Financial sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 38 shares — an estimated $2K sold.

Manchester Financial first reported a position in NEO in Q2 2019 and held it in 7 quarters. The position peaked at $17K in Q4 2019. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

  • Manchester Financial reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 38 NeoGenomics shares in Q2 2021, an estimated $2K.
  • Manchester Financial first reported a position in NeoGenomics in Q2 2019 and held it in 7 quarters.
  • Manchester Financial's NeoGenomics position peaked at $17K in Q4 2019.
  • 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.